Schizophrenia Research

Schizophrenia Research, published monthly by Elsevier in Amsterdam, is a prominent international journal dedicated to the multidisciplinary study of schizophrenia and related psychiatric conditions, identified by the ISSN 0920-9964. As a highly regarded platform within the field, the journal encompasses a broad scope of inquiry, including the etiology, diagnosis, treatment, and neurobiological mechanisms of the disorder, integrating insights from clinical practice, genetics, and neuroimaging. Indexed in the Science Citation Index (SCI), it maintains a strong reputation for rigorous peer review and high-quality scholarship, typically ranking in the second or third quartile of the Chinese Academy of Sciences (CAS) journal classification for medicine and psychiatry, with its specific standing reflecting its consistent impact factor as reported in the latest Journal Citation Reports. While the journal operates on a hybrid model that offers partial open access options, it is known for its competitive submission process and high rejection rates, demanding that authors demonstrate significant innovation and methodological excellence. Consequently, Schizophrenia Research serves as a critical venue for researchers and clinicians seeking to disseminate impactful work that advances the understanding and management of schizophrenia, provided that submissions meet the journal’s exacting standards for scientific rigor.